These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39080602)

  • 1. Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy.
    Zoto Mustafayev T; Turna M; Bolukbasi Y; Tezcanli E; Guney Y; Dincbas FO; Atasoy BM; Ugurluer G; Caglar HB; Atalar B; Ozyar E
    BMC Cancer; 2024 Jul; 24(1):918. PubMed ID: 39080602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
    Chung C; Bryant A; Brown PD
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
    Khan M; Zhao Z; Arooj S; Liao G
    BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
    Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
    J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
    Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
    Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
    J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis.
    Zhang J; Yu J; Yang D; Jiang L; Dong X; Liu Z; Yu R; Yu H; Shi A
    Front Immunol; 2024; 15():1399613. PubMed ID: 39257576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
    Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G
    Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
    Donovan EK; Parpia S; Greenspoon JN
    Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
    Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
    Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.
    Li J; He J; Cai L; Lai M; Hu Q; Ren C; Wen L; Wang J; Zhou J; Zhou Z; Li S; Ye M; Shan C; Chen L; Zhou C
    Ann Palliat Med; 2021 Feb; 10(2):2018-2026. PubMed ID: 33549015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.
    Vaios EJ; Batich KA; Buckley AF; Dunn-Pirio A; Patel MP; Kirkpatrick JP; Goudar R; Peters KB
    Oncotarget; 2022; 13():576-582. PubMed ID: 35359747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
    Sharma A; Mountjoy LJ; Butterfield RJ; Zhang N; Ross HJ; Schild SE; Sio TT; Daniels TB; Paripati HR; Mrugala MM; Vora SA; Patel NP; Zimmerman RS; Ashman JB; Porter AB
    Am J Clin Oncol; 2020 Feb; 43(2):128-132. PubMed ID: 31764021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
    Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
    J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.